1. Giapreza is an injection that increases blood pressure in adults with septic or other distributive shock.
2. Ixifi, Pfizer’s biosimilar version of Johnson & Johnson’s immunosuppressive drug Remicide, is intended to treat rheumatoid arthritis, Crohn’s disease and plaque psoriasis.
3. A novel gene therapy, Luxturna, treats a rare form of inherited vision loss that can result in complete blindness.
4. Nucala, a drug that treats severe asthma, is now approved to treat a rare autoimmune disease, eosinophilic granulomatosis with polyangiitis, which causes vasculitis, an inflammation in the wall of blood vessels.
6. Steglatro, approved to treat Type 2 diabetes, is a SGLT2 inhibitor, which works by causing patients to expel excess glucose through their urine.
More articles on supply chain:
Pfizer authorizes $10B share buyback
Two months after approval, Gilead’s ‘breakthrough’ cancer drug given to just a handful of patients
FDA launches website to improve management of antibiotic use
